Veröffentlichungen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Akalin, Altuna Dr. (1) Beule, Dieter Dr. (1) Birchmeier-Kohler, Carmen Prof. Dr. (2) Blankenstein, Thomas Prof. Dr. (2) Blüthgen, Nils (1) Bunse, Mario Dr. (1) Clauß, Julian (1) Daniel, Peter Prof. Dr. (1) Diecke, Sebastian Dr. (1) Gerhardt, Holger Prof. Dr. (1) Hinze, Christian Dr. med. Dipl.-Math. (1) Höpken, Uta Elisabeth PD Dr. (1) Ivics, Zoltan Dr. (1) Izsvak, Zsuzsanna Dr. (1) Kammertöns, Thomas Dr. (1) Kastelic, Nicolai (1) Kempa, Stefan Dr. (1) Kettenmann, Helmut Prof. Dr. (2) Kieback, Elisa Dr. (4) Kirchner, Marieluise Dr. (2) Kobelt, Dennis Dr. (1) Kühn, Ralf Dr. (1) Landthaler, Markus Prof. Dr. (1) Leisegang, Matthias Dr. (2) Lewin, Gary Prof. Dr. (1) Milek, Miha Dr. (1) Rajewsky, Nikolaus Prof. Dr. (1) Rehm, Armin Dr. (1) Rhein, Simone Dr. (1) Rudolph, Ina-Maria Dr. (1) Scheidereit, Claus Prof. Dr. (1) Sczakiel, Henrike (1) Selbach, Matthias Prof. Dr. (11) Uckert, Wolfgang Prof. Dr. (8) Uyar, Bora Dr. (1) Willnow, Thomas Prof. Dr. (1) Wolf, Susanne Dr. (1) Wollert-Wulf, Brigitte (2) Zauber, Henrik Dr. (3) (-) Janz, Martin Dr. (7) (-) Lusatis, Simone (1) (-) Mathas, Stephan Dr. (9) (-) Biologie maligner Lymphome (10) Genetik und Genomik von Herz- Kreislauferkrankungen (1) (-) Molekulare Zellbiologie und Gentherapie (1) Signaltransduktion in Tumorzellen (1) Systembiologie von Gen-regulatorischen Elementen (1) 1999 (1) 2000 (1) 2001 (1) 2002 (5) 2003 (3) 2004 (3) 2005 (3) (-) 2006 (5) 2007 (4) (-) 2008 (4) 2009 (4) 2010 (3) 2011 (4) 2012 (2) 2013 (3) 2014 (3) 2015 (5) 2016 (3) 2017 (5) (-) 2018 (1) 2019 (2) 2020 (6) 2021 (3) 2022 (9) 2023 (2) 10 Ergebnisse: Active Filter: Janz, Martin Dr.Lusatis, SimoneMathas, Stephan Dr.Biologie maligner LymphomeMolekulare Zellbiologie und Gentherapie200620082018 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. September 2018 / Leukemia The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma N. Schleussner O. Merkel M. Costanza H.C. Liang F. Hummel C. Romagnani P. Durek I. Anagnostopoulos M. Hummel K. Jöhrens A. Niedobitek P.R. Griffin R. Piva H.L. Sczakiel W. Woessmann C. Damm-Welk C. Hinze D. Stoiber B. Gillissen S.D. Turner E. Kaergel L. von Hoff M. Grau G. Lenz B. Dörken C. Scheidereit L. Kenner M. Janz S. Mathas 01. Dezember 2008 / Leukemia Notch inhibition blocks multiple myeloma cell-induced osteoclast activation R. Schwarzer M. Kaiser O. Acikgoez U. Heider S. Mathas R. Preissner O. Sezer B. Doerken F. Jundt 15. Oktober 2008 / Blood Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3α B. Lamprecht S. Kreher I. Anagnostopoulos K. Joehrens G. Monteleone F. Jundt H. Stein M. Janz B. Doerken S. Mathas 01. September 2008 / Haematologica The pathogenesis of classical Hodgkin's lymphoma: what can we learn from analyses of genomic alterations in Hodgkin and Reed-Sternberg cells? M. Janz S. Mathas 01. August 2008 / Leukemia Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin lymphoma F. Jundt O. Acikgoez S.H. Kwon R. Schwarzer I. Anagnostopoulos B. Wiesner S. Mathas M. Hummel H. Stein H.M. Reichardt B. Doerken 01. Juli 2006 / Blood Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma J.I. Martin-Subero I. Wlodarska C. Bastard J.M. Picquenot J. Hoeppner M. Giefing W. Klapper R. Siebert S. Mathas S. Joos H. Stein B. Doerken 15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas 01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
01. September 2018 / Leukemia The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma N. Schleussner O. Merkel M. Costanza H.C. Liang F. Hummel C. Romagnani P. Durek I. Anagnostopoulos M. Hummel K. Jöhrens A. Niedobitek P.R. Griffin R. Piva H.L. Sczakiel W. Woessmann C. Damm-Welk C. Hinze D. Stoiber B. Gillissen S.D. Turner E. Kaergel L. von Hoff M. Grau G. Lenz B. Dörken C. Scheidereit L. Kenner M. Janz S. Mathas
01. Dezember 2008 / Leukemia Notch inhibition blocks multiple myeloma cell-induced osteoclast activation R. Schwarzer M. Kaiser O. Acikgoez U. Heider S. Mathas R. Preissner O. Sezer B. Doerken F. Jundt
15. Oktober 2008 / Blood Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3α B. Lamprecht S. Kreher I. Anagnostopoulos K. Joehrens G. Monteleone F. Jundt H. Stein M. Janz B. Doerken S. Mathas
01. September 2008 / Haematologica The pathogenesis of classical Hodgkin's lymphoma: what can we learn from analyses of genomic alterations in Hodgkin and Reed-Sternberg cells? M. Janz S. Mathas
01. August 2008 / Leukemia Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin lymphoma F. Jundt O. Acikgoez S.H. Kwon R. Schwarzer I. Anagnostopoulos B. Wiesner S. Mathas M. Hummel H. Stein H.M. Reichardt B. Doerken
01. Juli 2006 / Blood Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma J.I. Martin-Subero I. Wlodarska C. Bastard J.M. Picquenot J. Hoeppner M. Giefing W. Klapper R. Siebert S. Mathas S. Joos H. Stein B. Doerken
15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken